Carlyle Group Inc.
WASHINGTON, DC · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 6, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$8.36B2026 Q3
Positions16
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%
What Changed This Quarter?
Top Holdings
MDLN
Medline
77.6%
SARO
StandardAero
21.6%
PHAT
Phathom Pharmaceuticals
0.3%
PONY
Pony AI
0.2%
INVH
Invitation Homes
0.1%
SPRB
Spruce Biosciences
0.0%
FWRD
Forward Air
0.0%
ACET
Adicet Bio
0.0%
Reduced / Exited
1 reduced · 3 sold out
INVH
Invitation Homes
0.2%
-28.0%
GETYEXIT
Getty Images
0.1%
QTTBEXIT
Q32 Bio
0.0%
REPXEXIT
Riley Exploration Permian
0.0%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.